HHS on Friday delayed the start of a rule issued by former President Donald Trump's administration that would eliminate manufacturer drug rebates paid to pharmacy benefit managers and Medicare Part D plans, in today's bite-sized hospital and health industry news from California and the District of Columbia.
Medicare Part D, also known as the Medicare prescription drug benefit, is a voluntary program funded by CMS that subsidizes the costs of outpatient prescription drugs and prescription drug insurance premiums for Medicare patients.
Download the cheat sheet to learn why Medicare Part D a key issue for providers, how Medicare Part D works, and how Medicare Part D impacts provider-supplier sales relationships.
Create your free account to access 2 resources each month, including the latest research and webinars.
You have 2 free members-only resources remaining this month remaining this month.
1 free members-only resources remaining this month
1 free members-only resources remaining this month
You've reached your limit of free monthly insights
Never miss out on the latest innovative health care content tailored to you.
You've reached your limit of free monthly insights